164 related articles for article (PubMed ID: 34162660)
1. Kaposi Sarcoma Incidence, Burden, and Prevalence in United States People with HIV, 2000-2015.
Peprah S; Engels EA; Horner MJ; Monterosso A; Hall HI; Johnson AS; Pfeiffer RM; Shiels MS
Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1627-1633. PubMed ID: 34162660
[TBL] [Abstract][Full Text] [Related]
2. Extracutaneous Kaposi sarcoma risk remains higher in people with HIV in the post-ART era.
Dinh S; Malmström S; Möller IK; Yilmaz A; Svedhem V; Carlander C
AIDS; 2023 Nov; 37(13):2041-2048. PubMed ID: 37451428
[TBL] [Abstract][Full Text] [Related]
3. Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.
Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
Clin Infect Dis; 2016 Nov; 63(10):1373-1379. PubMed ID: 27535953
[TBL] [Abstract][Full Text] [Related]
4. Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.
Kowalkowski MA; Kramer JR; Richardson PR; Suteria I; Chiao EY
Clin Infect Dis; 2015 May; 60(9):1405-14. PubMed ID: 25586682
[TBL] [Abstract][Full Text] [Related]
5. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
; Rohner E; Schmidlin K; Zwahlen M; Chakraborty R; Clifford G; Obel N; Grabar S; Verbon A; Noguera-Julian A; Collins IJ; Rojo P; Brockmeyer N; Campbell M; Chêne G; Prozesky H; Eley B; Stefan DC; Davidson A; Chimbetete C; Sawry S; Davies MA; Kariminia A; Vibol U; Sohn A; Egger M; Bohlius J
Clin Infect Dis; 2016 Nov; 63(9):1245-1253. PubMed ID: 27578823
[TBL] [Abstract][Full Text] [Related]
6. Kaposi Sarcoma Rates Among Persons Living With Human Immunodeficiency Virus in the United States: 2008-2016.
Luo Q; Satcher Johnson A; Hall HI; Cahoon EK; Shiels M
Clin Infect Dis; 2021 Oct; 73(7):e2226-e2233. PubMed ID: 33140823
[TBL] [Abstract][Full Text] [Related]
7. Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014.
White DL; Oluyomi A; Royse K; Dong Y; Nguyen H; Chang E; Richardson P; Jiao L; Garcia JM; Kramer JR; Thrift AP; Chiao E
J Acquir Immune Defic Syndr; 2019 Aug; 81(4):387-394. PubMed ID: 31242141
[TBL] [Abstract][Full Text] [Related]
8. Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men.
Luu HN; Amirian ES; Chiao EY; Scheurer ME
Cancer Med; 2014 Dec; 3(6):1635-43. PubMed ID: 25139791
[TBL] [Abstract][Full Text] [Related]
9. Risk of Nonkeratinocyte Skin Cancers in People Living with HIV during the Era of Antiretroviral Therapy.
Luu YT; Luo Q; Horner MJ; Shiels M; Engels EA; Sargen MR
J Invest Dermatol; 2023 Apr; 143(4):588-595.e3. PubMed ID: 36216206
[TBL] [Abstract][Full Text] [Related]
10. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in incidence & survival of Kaposi's sarcoma in the United States.
Kumar V; Soni P; Garg M; Hashmi AT; Chandra AB
Indian J Med Res; 2019 Mar; 149(3):354-363. PubMed ID: 31249200
[TBL] [Abstract][Full Text] [Related]
12. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy.
Jones JL; Hanson DL; Dworkin MS; Jaffe HW
J Acquir Immune Defic Syndr; 2000 Jul; 24(3):270-4. PubMed ID: 10969352
[TBL] [Abstract][Full Text] [Related]
13. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.
Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217
[TBL] [Abstract][Full Text] [Related]
14. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
Yanik EL; Achenbach CJ; Gopal S; Coghill AE; Cole SR; Eron JJ; Moore RD; Mathews WC; Drozd DR; Hamdan A; Ballestas ME; Engels EA
J Clin Oncol; 2016 Sep; 34(27):3276-83. PubMed ID: 27507879
[TBL] [Abstract][Full Text] [Related]
15. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.
Lodi S; Guiguet M; Costagliola D; Fisher M; de Luca A; Porter K;
J Natl Cancer Inst; 2010 Jun; 102(11):784-92. PubMed ID: 20442214
[TBL] [Abstract][Full Text] [Related]
16. The pattern of secondary cancers in patients with Kaposi sarcoma in the United States.
Kumar V; Garg M; Chaudhary N; Soni P; Floudas CS; Nwanyanwu C; Chandra A
Cancer Causes Control; 2017 Oct; 28(10):1065-1074. PubMed ID: 28900786
[TBL] [Abstract][Full Text] [Related]
17. Excess cancers among HIV-infected people in the United States.
Robbins HA; Pfeiffer RM; Shiels MS; Li J; Hall HI; Engels EA
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663691
[TBL] [Abstract][Full Text] [Related]
18. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
[TBL] [Abstract][Full Text] [Related]
19. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study.
Althoff KN; Stewart C; Humes E; Gerace L; Boyd C; Gebo K; Justice AC; Hyle EP; Coburn SB; Lang R; Silverberg MJ; Horberg MA; Lima VD; Gill MJ; Karris M; Rebeiro PF; Thorne J; Rich AJ; Crane H; Kitahata M; Rubtsova A; Wong C; Leng S; Marconi VC; D'Souza G; Kim HN; Napravnik S; McGinnis K; Kirk GD; Sterling TR; Moore RD; Kasaie P
PLoS Med; 2024 Jan; 21(1):e1004325. PubMed ID: 38215160
[TBL] [Abstract][Full Text] [Related]
20. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
